Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation

NCT04293809 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Augmentation

Interventions

DRUG: Exparel Injectable Product
DRUG: Bupivacaine Hydrochloride

Sponsor

Pacira Pharmaceuticals, Inc